Literature DB >> 24311857

A study on hypoglycaemic health care function of Stigma maydis polysaccharides.

Yan Zhang1, Jing-bo Wang, Liang Wang, Li-ying Zhen, Quang-qing Zhu, Xiao-wen Chen.   

Abstract

The objective of this paper was to study the therapeutic effect of Stigma maydis polysaccharides in diabetic mice. Mouse models of types 1 and 2 diabetes were established. The body weight, food intake, water intake as well as blood sugar level and glucose tolerance of mice were measured. Stigma maydis polysaccharides can improve the symptoms of weight loss and polydipsia in diabetic mice, and had an obvious antagonistic effect on alloxan-induced hyperglycaemia. The glucose tolerance test also showed that the Stigma maydis polysaccharides had very good effects on suppression and prevention of acute hyperglycaemia. Stigma maydis polysaccharides have some improvement effect on alloxan-induced types 1 and 2 diabetes.

Entities:  

Keywords:  Stigma maydis polysaccharides; hypoglycaemia; ultrasonic extraction

Mesh:

Substances:

Year:  2013        PMID: 24311857      PMCID: PMC3847437     

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  3 in total

1.  A new diabetes model induced by neonatal alloxan treatment in rats.

Authors:  T Kodama; M Iwase; K Nunoi; Y Maki; M Yoshinari; M Fujishima
Journal:  Diabetes Res Clin Pract       Date:  1993-06       Impact factor: 5.602

Review 2.  Animal models to test drugs with potential antidiabetic activity.

Authors:  T S Fröde; Y S Medeiros
Journal:  J Ethnopharmacol       Date:  2007-11-04       Impact factor: 4.360

3.  The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model.

Authors:  Ming Zhang; Xiao-Yan Lv; Jing Li; Zhi-Gang Xu; Li Chen
Journal:  Exp Diabetes Res       Date:  2009-01-04
  3 in total
  1 in total

Review 1.  Applicability of Isolates and Fractions of Plant Extracts in Murine Models in Type II Diabetes: A Systematic Review.

Authors:  Gabriela Diniz Pinto Coelho; Vanessa Soares Martins; Laura Vieira do Amaral; Rômulo Dias Novaes; Mariáurea Matias Sarandy; Reggiani Vilela Gonçalves
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-24       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.